Marked Enhanced Myometrium Vascularity: Arteriovenous Malformation or Retained Product of Conception: A Case Report
Journal of Obstetrics, Gynecology and Cancer Research · 07.05.2026 · 11 (5) · 442-446
DOI: 10.24200/jogcr.11.5.442 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Obstetrics, Gynecology and Cancer Research, online erschienen am 07.05.2026. Verfasst von Asieh Maleki und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Maleki, A., lotfi, G., & mohammadi, S. A. (2026). Marked Enhanced Myometrium Vascularity: Arteriovenous Malformation or Retained Product of Conception: A Case Report. Journal of Obstetrics, Gynecology and Cancer Research, 11(5), 442-446. https://doi.org/10.24200/jogcr.11.5.442
Vancouver
Maleki A, lotfi G, mohammadi SA. Marked Enhanced Myometrium Vascularity: Arteriovenous Malformation or Retained Product of Conception: A Case Report. Journal of Obstetrics, Gynecology and Cancer Research. 2026;11(5):442-446. doi:10.24200/jogcr.11.5.442
BibTeX
@article{Maleki2026,
author = {Maleki, Asieh and lotfi, Ghazale and mohammadi, Seyed Ali},
title = {Marked Enhanced Myometrium Vascularity: Arteriovenous Malformation or Retained Product of Conception: A Case Report},
journal = {Journal of Obstetrics, Gynecology and Cancer Research},
year = {2026},
volume = {11},
number = {5},
pages = {442--446},
doi = {10.24200/jogcr.11.5.442}
}
EUVIMED